Roche Seeks Fast-Track US Approval of Ebola Diagnostic Test

by Himabindu Venkatakrishnan on  October 27, 2014 at 8:54 AM Tropical Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

A rapid diagnostic test for Ebola has been developed by Swiss pharmaceutical group Roche and hopes to obtain fast-track US approval for it. The company's director general declared this in an interview published Sunday, amid the worst-ever outbreak of the killer disease.
Roche Seeks Fast-Track US Approval of Ebola Diagnostic Test
Roche Seeks Fast-Track US Approval of Ebola Diagnostic Test

The diagnostic test is ready for use in scientific research but the company now wants to register it for clinical use.

Roche has filed for European Union approval of the test and plans shortly to do the same with US health authorities, CEO Severin Schwan told the Swiss German SonntagsZeitung newspaper.

"We hope that they will grant us an accelerated authorization procedure," Schwan said.

More than 10,000 people have contracted the Ebola virus, according to the latest World Health Organization figures, mainly in the west African countries of Liberia, Sierra Leone and Guinea.

More than 4,900 people have died of the hemorrhagic virus, according to the figures from October 23.

Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Varicocele Congo Fever Testicle Pain - Symptom Evaluation Ebola Virus Disease 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive